Wednesday, February 10, 2010, 8:48am EST - Canadian Markets open in 42 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Jazz Pharmaceuticals, Inc. (JAZZ)

 On Feb 9: 9.18 USD   0.00 (0.00%)  
MORE ON JAZZ
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Jazz Pharmaceuticals, Inc. (NGM:JAZZ) Delayed quote dataEdit
Last Trade: 9.18 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 9.18
Open: N/A
Bid: 8.54 x 500
Ask: 9.65 x 1400
1y Target Est: 10.50
Day's Range: N/A - N/A
52wk Range: 0.52 - 11.88
Volume: 0
Avg Vol (3m): 349,919
Market Cap: 284.51M
P/E (ttm): N/A
EPS (ttm): -2.38
Div & Yield: N/A (N/A%)
Jazz Pharmaceuticals, Inc. (JAZZ)
1d  5d  3m  6m  1y  2y  5y 
 Add JAZZ to Portfolio   Download Data

HEADLINES
• JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Wed, Jan 20)
• Jazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference
PRNewswire (Thu, Jan 7)
• Lightning Round OT: Tekelec, Jazz Pharma and More
at CNBC (Wed, Dec 16)
• Jazz Pharmaceuticals Submits New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
PRNewswire (Tue, Dec 15)
• [$$] Dollar Drives the Action
at RealMoney by TheStreet.com (Thu, Dec 10)
• Buying Strength? Don't Do It! 3 PowerRatings Stocks To Test
TradingMarkets.com (Wed, Dec 9)
• Coverage initiated on Jazz Pharma by Jefferies & Co
Briefing.com (Wed, Dec 9)
• Jazz Pharmaceuticals appoints ARCA exec as CFO
AP (Thu, Dec 3)
• Jazz Pharmaceuticals names CFO
at bizjournals.com (Thu, Dec 3)
• Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer
PRNewswire (Thu, Dec 3)
More Headlines for JAZZ...
ANALYST
EPS Est (next year) (Dec-09) : -0.36
EPS Est (in 2 years) (Dec-10) : 0.36
Avg Rec (current)*: 2.5
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices